US Patent Number
An inactivated viral vaccine for protecting horses against disease caused by equine rhinopneumonitis virus is prepared by propagating an equine rhinopneumonitis virus in a susceptible, cloned, diploid equine cell line, harvesting the resulting virus in a serum-free medium, inactivating the virus and neutralizing the inactivating agent, concentrating the virus, and adding an immunological adjuvant thereto. A vaccination program to protect horses against the equine rhinopneumonitis virus is also disclosed.
University of Kentucky Research Foundation, Lexington, Ky.
Bryans, John T., "Inactivated Equine Rhinopneumonitis Virus Vaccine and Use Thereof" (1978). Veterinary Science Faculty Patents. 10.